HomeIndustry News › Cellular Health

Health Canada warns against injecting unauthorized drugs promising anti-aging, weight loss or wellness – CBC

Cellular Health: Health Canada warns against injecting unauthorized drugs promising anti-aging, weight loss or wellness – CBC

Health Canada has issued a public warning against the use of unauthorized injectable drugs marketed with promises of anti-aging benefits, weight loss, or general wellness improvements. The regulatory agency is cautioning consumers about the serious health risks associated with these products, which have not undergone the rigorous safety and efficacy evaluations required for approved medications in Canada.

The warning comes amid growing concerns about the proliferation of unregulated injectable substances being promoted through social media, online marketplaces, and wellness clinics. These products often claim to offer cellular rejuvenation, metabolic enhancement, or other health benefits without the backing of scientific evidence or regulatory approval. Health Canada emphasized that the use of such unauthorized drugs can lead to severe adverse reactions, including infections, allergic responses, tissue damage, and other potentially life-threatening complications.

The issue reflects a broader trend in the wellness industry, where consumers increasingly seek quick-fix solutions for weight management and aging. While legitimate pharmaceutical interventions exist for certain conditions, the regulatory body warns that unauthorized alternatives bypass critical safety protocols designed to protect public health. These unvetted products may contain unknown ingredients, improper dosages, or contaminants that pose significant risks to users.

Health Canada is urging consumers to consult licensed healthcare providers before considering any injectable treatments and to verify that any prescribed medications are authorized for sale in Canada. The agency also advises reporting any adverse reactions or suspected unauthorized products to help protect others from potential harm. For individuals seeking weight loss or anti-aging solutions, the message is clear: shortcuts that bypass proper medical oversight can carry serious consequences that far outweigh any promised benefits.

← Previous Genetic predictors of GLP1 receptor agonist weight loss and side effects - Nature Next → Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S. - Eli Lilly

Get the Weekly Digest

Research highlights, community picks, and expert insights — every week.

← Back to All News

Popular telehealth providers in this space

Disclosure: The links below are affiliate links — if you click through and make a purchase, GLPbase may earn a small commission at no additional cost to you. This section does not constitute medical advice or a recommendation to seek treatment. Any healthcare decisions are solely between you and your provider. These links do not affect the article above, which is independently researched and written before any affiliate links are added. Our editorial team does not receive commissions, and our analysis is never influenced by affiliate partnerships. For more details, see our Editorial Policy.